Volume 28, Issue 2 (Summer 2022)                   IJPCP 2022, 28(2): 162-181 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Masoumian S, Gharraee B, Ramezani Farani A, Shaeiri M R, Asgharnejadfarid A A. Comparing the Effectiveness of Schema Therapy Augmented Exposure and Response Prevention With Exposure and Response Prevention and Pharmacotherapy in Obsessive-compulsive Disorder. IJPCP 2022; 28 (2) :162-181
URL: http://ijpcp.iums.ac.ir/article-1-3274-en.html
1- Department of Clinical Psychology, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran.
2- Department of Clinical Psychology, Faculty of Humanities, Shahed University, Tehran, Iran.
3- Department of Clinical Psychology, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Iran University of Medical Sciences, Tehran, Iran. , asgharnejadfarid.as@iums.ac.ir
Abstract:   (3743 Views)
Objectives: Obsessive-compulsive disorder (OCD) is defined in the diagnostic and statistical manual of mental disorders, 5th Edition (DSM-5) as annoying and unpleasant thoughts or images (obsession) associated with repetitive and unwanted actions (compulsion). This study aims to compare emotional schema therapy augmented exposure and response prevention (ESTERP) with exposure and response prevention (ERP) and pharmacotherapy in improving the symptoms of OCD patients.
Methods: This was a randomized clinical trial study. The participants included all patients with OCD who were referred to hospitals and clinics in Tehran, Iran. A total of 45 patients with OCD were selected through purposeful sampling, of which 15 patients were randomly assigned to the ESTERP group, 15 to the ERP group, and 15 to the pharmacotherapy group. After randomly placing the patients in the three groups, all patients completed the Yale-Brown obsessive-compulsive scale-2nd edition (Y-BOCS-II), the four systems anxiety questionnaire (FSAQ), and the Beck depression inventory-2nd edition (BDI-II) before, in the end, and 2 months after the treatment. Then, the data were analyzed using nonparametric tests and the reliable change index.
Results: There was a significant difference between the treatment of ESTERP with ERP and pharmacotherapy in the symptoms and severity of OCD and anxiety (except for the depression variable) in patients with OCD. In addition, the findings of the clinical significance of ESTERP compared to the other two treatments showed more significant changes in symptoms and severity of OCD and depression (except for the anxiety variable).
Conclusion: Both ESTERP and ERP treatments are effective in patients with OCD and both lead to more improvements in patients’ symptoms than pharmacotherapy.
Full-Text [PDF 7846 kb]   (1420 Downloads) |   |   Full-Text (HTML)  (992 Views)  
Type of Study: Original Research | Subject: Psychiatry and Psychology
Received: 2020/06/20 | Accepted: 2021/08/10 | Published: 2022/07/1

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Psychiatry and Clinical Psychology

Designed & Developed by : Yektaweb